| Sources | Names Used |
|---|---|
| CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
| PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ITGBL1 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | ETS1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | ARFGAP3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | TMEM150B | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | FERMT3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | CREB3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | STK26 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | NXPH4 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | C12orf10 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | ERCC5 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
